Supply Chain Intelligence

ADC Therapeutics SA Supply Chain

ADCT supply chain intelligence for ADC Therapeutics SA: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ADCT ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
5Customers
3Debt Items
20Related Chains

ADC Therapeutics SA Suppliers

TickerNameConfidenceEvidence
HEALTHCARE-ROYALTY-MANAGEMENT-LLC HEALTHCARE-ROYALTY-MANAGEMENT-LLC 80% The Company is relying on this exemption from registration based in part on representations made in the warrants.
PYXS Pyxis Oncology, Inc. 72% Reciprocal relationship from PYXS graph: ter prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitab…

ADC Therapeutics SA Customers

TickerNameConfidenceEvidence
CAH Cardinal Health, Inc. 92% Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 Cardinal Health 25…
CAH Cardinal Health, Inc. 92% Reciprocal relationship from CAH graph: Reciprocal relationship from ADCT graph: Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 a…
MCK McKesson Corporation 92% Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 McKesson 36 % 34 %
MCK McKesson Corporation 92% Reciprocal relationship from MCK graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from MCK graph: Reciprocal relationship from ADCT graph: Customers from which we derive more t…
PYXS Pyxis Oncology, Inc. 72% Reciprocal relationship from PYXS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from PYXS graph: ter prove to have greater commercial potential. Our resource allocation deci…

ADC Therapeutics SA Debt Obligations

InstrumentDescriptionConfidenceEvidence
ADCT-DEBT Debt stack $436.3M 90% Market cache reports total debt of $436.3M.
ADCT-DEBT-7505 Warrants outstanding: 27743685 90% xbrl warrant detail from xbrl 2026-03-31.
ADCT-DEBT-7506 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.

ADC Therapeutics SA Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ADC Therapeutics SA.

ADC Therapeutics SA Ownership

HolderNameConfidenceEvidence
ADCT-OWNER-REDMILE-GROUP-LLC Redmile Group, LLC 90% 13F overlay lists Redmile Group, LLC as top holder; 118 tracked holders.

ADC Therapeutics SA Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GILD Gilead Sciences, Inc. 100.00 2
GNMSF Genmab A/S 100.00 2
HLNCF Haleon plc 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
HALO Halozyme Therapeutics, Inc. 100.00 2
HLN Haleon plc 100.00 2
CLDX Celldex Therapeutics, Inc. 100.00 2
ARDX Ardelyx, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
ESTA Establishment Labs Holdings Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
GRDN Guardian Pharmacy Services, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
CAH Cardinal Health, Inc. 100.00 1 ['customer']
CLH Clean Harbors, Inc. 100.00 2
CVS CVS Health Corporation 100.00 2
ACAD ACADIA Pharmaceuticals Inc. 100.00 2
FBIO Fortress Biotech, Inc. 100.00 2
View ADCT supply chain intel →

Explore the full interactive supply chain map for ADC Therapeutics SA.

Open ADCT supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map